These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 30810470)

  • 1. Infections Caused by Carbapenemase-Producing Klebsiella pneumoniae: Microbiological Characteristics and Risk Factors.
    Pan H; Lou Y; Zeng L; Wang L; Zhang J; Yu W; Qiu Y
    Microb Drug Resist; 2019 Mar; 25(2):287-296. PubMed ID: 30810470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bloodstream infections caused by metallo-β-lactamase/Klebsiella pneumoniae carbapenemase-producing K. pneumoniae among intensive care unit patients in Greece: risk factors for infection and impact of type of resistance on outcomes.
    Mouloudi E; Protonotariou E; Zagorianou A; Iosifidis E; Karapanagiotou A; Giasnetsova T; Tsioka A; Roilides E; Sofianou D; Gritsi-Gerogianni N
    Infect Control Hosp Epidemiol; 2010 Dec; 31(12):1250-6. PubMed ID: 20973725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors, outcomes and genotypes of carbapenem-nonsusceptible Klebsiella pneumoniae bloodstream infection: a three-year retrospective study in a large tertiary hospital in Northern China.
    Zheng SH; Cao SJ; Xu H; Feng D; Wan LP; Wang GJ; Xiao XG
    Infect Dis (Lond); 2018 Jun; 50(6):443-451. PubMed ID: 29303020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of Klebsiella pneumoniae strains producing carbapenemases and increase of resistance to colistin in an Italian teaching hospital from January 2012 To December 2014.
    Parisi SG; Bartolini A; Santacatterina E; Castellani E; Ghirardo R; Berto A; Franchin E; Menegotto N; De Canale E; Tommasini T; Rinaldi R; Basso M; Stefani S; Palù G
    BMC Infect Dis; 2015 Jun; 15():244. PubMed ID: 26116560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbapenem Nonsusceptible Klebsiella pneumoniae in Taiwan: Dissemination and Increasing Resistance of Carbapenemase Producers During 2012-2015.
    Chiu SK; Ma L; Chan MC; Lin YT; Fung CP; Wu TL; Chuang YC; Lu PL; Wang JT; Lin JC; Yeh KM
    Sci Rep; 2018 May; 8(1):8468. PubMed ID: 29855588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outbreak by Hypermucoviscous
    Zhan L; Wang S; Guo Y; Jin Y; Duan J; Hao Z; Lv J; Qi X; Hu L; Chen L; Kreiswirth BN; Zhang R; Pan J; Wang L; Yu F
    Front Cell Infect Microbiol; 2017; 7():182. PubMed ID: 28560183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microbiological and molecular characteristics of carbapenemase-producing Klebsiella pneumoniae endemic in a tertiary Greek hospital during 2004-2010.
    Zagorianou A; Sianou E; Iosifidis E; Dimou V; Protonotariou E; Miyakis S; Roilides E; Sofianou D
    Euro Surveill; 2012 Feb; 17(7):. PubMed ID: 22370015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular epidemiology and risk factors for colistin- or tigecycline-resistant carbapenemase-producing Klebsiella pneumoniae bloodstream infection in critically ill patients during a 7-year period.
    Papadimitriou-Olivgeris M; Bartzavali C; Spyropoulou A; Lambropoulou A; Sioulas N; Vamvakopoulou S; Karpetas G; Spiliopoulou I; Vrettos T; Anastassiou ED; Fligou F; Christofidou M; Marangos M
    Diagn Microbiol Infect Dis; 2018 Nov; 92(3):235-240. PubMed ID: 30076041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors and clinical outcomes of hypervirulent Klebsiella pneumoniae induced bloodstream infections.
    Li J; Ren J; Wang W; Wang G; Gu G; Wu X; Wang Y; Huang M; Li J
    Eur J Clin Microbiol Infect Dis; 2018 Apr; 37(4):679-689. PubMed ID: 29238932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Triple combination antibiotic therapy for carbapenemase-producing Klebsiella pneumoniae: a systematic review.
    Jacobs DM; Safir MC; Huang D; Minhaj F; Parker A; Rao GG
    Ann Clin Microbiol Antimicrob; 2017 Nov; 16(1):76. PubMed ID: 29178957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Resistance Mechanisms on the Inoculum Effect of Carbapenem in Klebsiella pneumoniae Isolates with Borderline Carbapenem Resistance.
    Adler A; Ben-Dalak M; Chmelnitsky I; Carmeli Y
    Antimicrob Agents Chemother; 2015 Aug; 59(8):5014-7. PubMed ID: 25987630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clonal replacement of epidemic KPC-producing Klebsiella pneumoniae in a hospital in China.
    Liang Y; Yin X; Zeng L; Chen S
    BMC Infect Dis; 2017 May; 17(1):363. PubMed ID: 28535790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intra-hospital acquisition of colonization and infection by Klebsiella pneumoniae strains producing carbapenemases and carriage evolution: A longitudinal analysis in an Italian teaching hospital from January 2017 to August 2019.
    Basso M; Zago D; Pozzetto I; De Canale E; Scaggiante R; Biasolo MA; Peracchi M; Onelia F; Baldasso E; Palù G; Parisi SG
    Int J Infect Dis; 2020 Mar; 92():81-88. PubMed ID: 31935535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hospital outbreak due to a Klebsiella pneumoniae ST147 clonal strain co-producing KPC-2 and VIM-1 carbapenemases in a tertiary teaching hospital in Northern Greece.
    Protonotariou E; Poulou A; Politi L; Sgouropoulos I; Metallidis S; Kachrimanidou M; Pournaras S; Tsakris A; Skoura L
    Int J Antimicrob Agents; 2018 Sep; 52(3):331-337. PubMed ID: 29654892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Control of carbapenemase-producing Klebsiella pneumoniae: a region-wide intervention.
    Gagliotti C; Cappelli V; Carretto E; Marchi M; Pan A; Ragni P; Sarti M; Suzzi R; Tura GA; Moro ML;
    Euro Surveill; 2014 Oct; 19(43):. PubMed ID: 25375901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for infection and predictors of mortality among patients with KPC-producing Klebsiella pneumoniae bloodstream infections in the intensive care unit.
    Papadimitriou-Olivgeris M; Marangos M; Christofidou M; Fligou F; Bartzavali C; Panteli ES; Vamvakopoulou S; Filos KS; Anastassiou ED
    Scand J Infect Dis; 2014 Sep; 46(9):642-8. PubMed ID: 25017796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergence of carbapenem-resistant Klebsiella Pneumoniae strains producing KPC-3 in Brescia Hospital, Italy.
    Corbellini S; Caccuri F; Gelmi M; De Francesco MA; Fiorentini S; Caruso A; Giagulli C
    New Microbiol; 2014 Apr; 37(2):177-83. PubMed ID: 24858644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular epidemiology of carbapenemase-producing Klebsiella pneumoniae in a hospital in Madrid: Successful establishment of an OXA-48 ST11 clone.
    Brañas P; Villa J; Viedma E; Mingorance J; Orellana MA; Chaves F
    Int J Antimicrob Agents; 2015 Jul; 46(1):111-6. PubMed ID: 25914088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular epidemiology of carbapenem-resistant Klebsiella pneumoniae at a Turkish centre: Is the increase of resistance a threat for Europe?
    Candevir Ulu A; Güven Gökmen T; Kibar F; Kurtaran B; Önlen C; Kuşçu F; İnal AS; Kömür S; Yaman A; Aksu HSZ; Taşova Y
    J Glob Antimicrob Resist; 2017 Dec; 11():10-16. PubMed ID: 28743652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The emergence of bla
    Moghadampour M; Rezaei A; Faghri J
    Acta Microbiol Immunol Hung; 2018 Aug; 65(3):335-344. PubMed ID: 30024268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.